HURN
NASD Huron Consulting Group Inc.$156.83 ↑ +0.00 (+0.00%) Trading Up from the previous close of $156.83, $0.96 below the day’s high of $157.80
- YTD change
- -9.30%
- vs 20-day SMA
- +0.82%
- vs 200-day SMA
- +13.24%
Price ranges
Price & Performance
+30.76 (+24.40%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 16.0% away from all-time highs of $186.78
- HURN is down 9% since the beginning of the year
- HURN is up 7% over the past 12 months
- HURN is down 2% over the past 1 month
- 5% of all HURN investors are betting against HURN
HURN reads neutral: price sits above both the 20- and 200-day averages, the 12-month move is +6.9%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -0.65%
- vs 8-day SMA
- -0.81%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Huron Consulting Group, Inc. engages in the provision of technology, data, and analytics solutions. It operates through the following segments: Healthcare, Education, and Commercial. The Healthcare segment focuses on serving acute care providers including national and regional health systems, academic health systems, and community health systems, and public, children, and critical access hospitals, and non-acute care providers including physician practices and medical groups, payors, and long-term care or post-acute providers. The Education segment is involved in public and private colleges and universities, research institutes, and other education-related organizations. The Commercial segment includes industries outside of healthcare and education including financial services and energy and utilities. The company was founded in 2002 and is headquartered in Chicago, IL.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.